Jan Bauer
About
Jan Bauer is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology.
According to data from OpenAlex, Jan Bauer has authored 221 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Immunology, 63 papers in Pathology and Forensic Medicine and 55 papers in Molecular Biology. Recurrent topics in Jan Bauer's work include Multiple Sclerosis Research Studies (59 papers), Neuroinflammation and Neurodegeneration Mechanisms (53 papers) and T-cell and B-cell Immunology (38 papers). Jan Bauer is often cited by papers focused on Multiple Sclerosis Research Studies (59 papers), Neuroinflammation and Neurodegeneration Mechanisms (53 papers) and T-cell and B-cell Immunology (38 papers). Jan Bauer collaborates with scholars based in Austria, Germany and Netherlands. Jan Bauer's co-authors include Hans Lassmann, Christian G. Bien, Bert A. ‘t Hart, Roland Liblau, Monika Bradl, Frank Thorn, Richard Held, Jane Gwiazda, Thomas Berger and Jon D. Laman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
In The Last Decade
Jan Bauer
214 papers receiving 14.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jan Bauer Austria | 68 | 4.1k | 4.1k | 3.7k | 3.4k | 2.5k | 221 | 14.5k | ||
| Frauke Zipp Germany | 62 | 3.6k 0.9× | 4.7k 1.2× | 3.3k 0.9× | 3.2k 0.9× | 2.1k 0.8× | 308 | 13.6k | ||
| Alexandre Prat Canada | 61 | 5.1k 1.2× | 3.7k 0.9× | 5.9k 1.6× | 4.6k 1.3× | 1.8k 0.7× | 209 | 16.2k | ||
| Sandra Amor Netherlands | 61 | 3.9k 0.9× | 3.1k 0.8× | 4.3k 1.2× | 3.6k 1.1× | 1.4k 0.6× | 198 | 12.4k | ||
| Francesca Aloisi Italy | 62 | 6.7k 1.6× | 5.1k 1.3× | 5.2k 1.4× | 3.2k 0.9× | 2.0k 0.8× | 130 | 15.9k | ||
| Sven G. Meuth Germany | 59 | 2.7k 0.6× | 3.1k 0.8× | 2.6k 0.7× | 4.1k 1.2× | 2.2k 0.9× | 561 | 14.0k | ||
| Christine Stadelmann Germany | 69 | 3.8k 0.9× | 6.7k 1.7× | 4.8k 1.3× | 4.5k 1.3× | 3.0k 1.2× | 229 | 17.3k | ||
| Fredrik Piehl Sweden | 64 | 2.7k 0.6× | 5.7k 1.4× | 2.0k 0.5× | 3.7k 1.1× | 4.1k 1.6× | 324 | 15.1k | ||
| Roberto Furlan Italy | 62 | 2.7k 0.6× | 3.1k 0.8× | 3.3k 0.9× | 4.8k 1.4× | 2.4k 1.0× | 235 | 13.7k | ||
| Helga E. de Vries Netherlands | 74 | 3.0k 0.7× | 2.5k 0.6× | 5.5k 1.5× | 6.2k 1.8× | 1.5k 0.6× | 257 | 16.8k | ||
| William F. Hickey United States | 62 | 4.9k 1.2× | 1.8k 0.4× | 4.7k 1.3× | 3.8k 1.1× | 1.5k 0.6× | 190 | 15.6k |
Countries citing papers authored by Jan Bauer
Since
Specialization
Citations
This map shows the geographic impact of Jan Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Bauer more than expected).
Fields of papers citing papers by Jan Bauer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jan Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Bauer. The network helps show where Jan Bauer may publish in the future.
Co-authorship network of co-authors of Jan Bauer
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Bauer. A scholar is included among the top collaborators of Jan Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Bauer. Jan Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Roll, Wolfgang, Jan Bauer, Andre Dik, et al.. (2024). [18F]DPA-714-PET-MRI reveals pronounced innate immunity in human anti-LGI1 and anti-CASPR2 limbic encephalitis. Journal of Neurology. 271(6). 3653–3659.
2.
Matthys, Patrick, et al.. (2024). CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis. Nature Communications. 15(1). 5013–5013.
3.
Winklehner, Michael, Jonathan Wickel, Ellen Gelpí, et al.. (2024). Progressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies. Neurology Neuroimmunology & Neuroinflammation. 11(6). e200298–e200298.
4.
Dorninger, Fabian, Attila Kiss, Theresa König, et al.. (2023). Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency. International Journal of Molecular Sciences. 24(3). 1884–1884.
5.
Ponleitner, Markus, Yoshiki Takai, Daniel Hofmann, et al.. (2023). Paths to hippocampal damage in neuromyelitis optica spectrum disorders. Neuropathology and Applied Neurobiology. 49(2). e12893–e12893.
6.
Aydin, Sidar, Britta Engelhardt, Rachel R Caspi, et al.. (2023). Effects of a Small-Molecule Perforin Inhibitor in a Mouse Model of CD8 T Cell–Mediated Neuroinflammation. Neurology Neuroimmunology & Neuroinflammation. 10(4).
7.
Weinhofer, Isabelle, Markus Kunze, Zsófia Pálfi, et al.. (2022). Peroxisomal very long-chain fatty acid transport is targeted by herpesviruses and the antiviral host response. Communications Biology. 5(1). 944–944.
8.
Strippel, Christine, Anna R. Tröscher, Tobias Baumgartner, et al.. (2022). Complement activation contributes to GAD antibody-associated encephalitis. Acta Neuropathologica. 144(2). 381–383.
9.
Rodríguez‐Pascau, Laura, Anna Vilalta, Sonja Forss‐Petter, et al.. (2021). The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Science Translational Medicine. 13(596).
10.
Bernard‐Valnet, Raphaël, Xuan‐Hung Nguyen, Clémence Queriault, et al.. (2021). Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy. Brain. 145(6). 2018–2030.
11.
Pákozdy, Ákos, Péter Halász, Andrea Klang, et al.. (2012). Suspected Limbic Encephalitis and Seizure in Cats Associated with Voltage-Gated Potassium Channel (VGKC) Complex Antibody. Journal of Veterinary Internal Medicine. 27(1). 212–214.
12.
Málaga-Diéguez, Laura, et al.. (2010). Pharmacochaperoning of the A1 Adenosine Receptor Is Contingent on the Endoplasmic Reticulum. Molecular Pharmacology. 77(6). 940–952.
13.
Saxena, Amit, Jan Bauer, Jacques Zappulla, et al.. (2008). Cutting Edge: Multiple Sclerosis-Like Lesions Induced by Effector CD8 T Cells Recognizing a Sequestered Antigen on Oligodendrocytes. The Journal of Immunology. 181(3). 1617–1621.
14.
Adams, Ryan A., Jan Bauer, Matthew J. Flick, et al.. (2007). The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. The Journal of Experimental Medicine. 204(3). 571–582.
15.
Hart, Bert A. ‘t, Herbert Brok, Ed Remarque, et al.. (2005). Suppression of Ongoing Disease in a Nonhuman Primate Model of Multiple Sclerosis by a Human-Anti-Human IL-12p40 Antibody. The Journal of Immunology. 175(7). 4761–4768.
16.
Boon, Louis, Herbert Brok, Jan Bauer, et al.. (2001). Prevention of Experimental Autoimmune Encephalomyelitis in the Common Marmoset ( Callithrix jacchus ) Using a Chimeric Antagonist Monoclonal Antibody Against Human CD40 Is Associated with Altered B Cell Responses. The Journal of Immunology. 167(5). 2942–2949.
17.
Kassiotis, George, Jan Bauer, Katerina Akassoglou, et al.. (1999). A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. European Journal of Immunology. 29(3). 912–917.
18.
Kassiotis, George, Jan Bauer, Katerina Akassoglou, et al.. (1999). A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. European Journal of Immunology. 29(3). 912–917.
19.
Bauer, Jan, Tilman Bauer, Thomas Kalb, et al.. (1989). Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes.. The Journal of Experimental Medicine. 170(5). 1537–1549.
20.
Northoff, Hinnak, Tilo Andus, T A Tran-Thi, et al.. (1987). TUMOR-NECROSIS-FACTOR (TNF), INTERFERON-ALPHA, INTERFERON-GAMMA AND INTERFERON-BETA-1 DO NOT EXHIBIT HEPATOCYTE STIMULATING (HSF) ACTIVITY. University of Regensburg Publication Server (University of Regensburg).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Frauke Zipp Breakdown of academic impact, for papers by Alexandre Prat Breakdown of academic impact, for papers by Sandra Amor Breakdown of academic impact, for papers by Francesca Aloisi Breakdown of academic impact, for papers by Sven G. Meuth Breakdown of academic impact, for papers by Christine Stadelmann Breakdown of academic impact, for papers by Fredrik Piehl Breakdown of academic impact, for papers by Roberto Furlan Breakdown of academic impact, for papers by Helga E. de Vries Breakdown of academic impact, for papers by William F. Hickey